Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers 2025-06-23 08:03
Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations 2025-06-19 18:08
111, Inc. Announces First Quarter 2025 Unaudited Financial Results 2025-06-19 15:03
Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Patients with Relapsed/Refractory Multiple Myeloma 2025-06-19 08:37
MedHub-AI Receives PMDA Approval in Japan for AutocathFFR® 2025-06-19 07:00
Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer 2025-06-18 22:36
Largest Australian Health Insurer to Fund Innovative PTSD Treatment Program 2025-06-18 20:00
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets 2025-06-18 08:00
AI-Powered CDSS Enhances Patient Safety with Real-World Data 2025-06-18 00:05
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx 2025-06-17 21:04
HanchorBio Presents Promising Data on HCB101 Checkpoint Inhibitor Immunotherapy at ASCO 2025-06-17 18:00
VSA Signs Letter of Intent to Acquire HopeAI, Accelerating Expansion into AI in Life Science 2025-06-17 16:30
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates 2025-06-17 12:48
CodeSteri Launches PlaDeo: The World's First Bio-Plasma Powered Deodorant Device 2025-06-17 01:00
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China 2025-06-16 22:40
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology 2025-06-16 21:03
American Migraine Foundation Highlights HeadaTerm2 in Its Latest Device Recommendations, Backed by Clinical Evidence 2025-06-16 21:00
China National Intellectual Property Administration Affirms Validity of Harbour BioMed's Patent; Infringement Lawsuit Moves Forward 2025-06-16 20:33
BioDlink's Bevacizumab Approved for Market Launch in Nigeria, Accelerating Global Expansion 2025-06-16 20:30
"Luminous Path, Shared Stride - Brazil and China" 2025-06-16 20:08
1 26 27 28 29 30 491